Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 3/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentoxazone SCHEMBL7584420 | 0.88 | PPARG (0.33) | PPOXL3MBTL1PDE4DPKMPPARG | |
| Pentoxazone SCHEMBL7934081 | 0.88 | PKM (0.39) | PPOXL3MBTL1PDE4DPKMMAPT | |
| Pentoxazone SCHEMBL7588179 | 0.88 | PPOX (0.41) | PPOXL3MBTL1FFAR1MAPTSMN1; SMN2 | |
| Pentoxazone SCHEMBL7578499 | 0.87 | PPOX (0.36) | PPOXL3MBTL1PDE4DPKMPPARG | |
| Flumipropyn SCHEMBL7587564 | 0.80 | PKM (0.34) | PPOXPKMHTTPPARGMAPT | |
| Flumiciorac-Pentyl SCHEMBL7581994 | 0.79 | ALDH1A1 (0.38) | PPOXL3MBTL1PKMHTTPPARG | |
| Pentoxazone SCHEMBL7593907 | 0.77 | PDE4D (0.34) | L3MBTL1PDE4DPKM | |
| Flumioxazin SCHEMBL7581418 | 0.76 | KMO (0.34) | PKMPPARG | |
| Pentoxazone SCHEMBL7587759 | 0.76 | — | — | |
| Flazasulfuron SCHEMBL7586903 | 0.76 | SCN1A (0.34) | PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | PPOX 1/4885L3MBTL1 2160/4885PDE4D 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.